5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)
Title:
5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)
Author:
Bosch, Francesc Abrisqueta, Pau Villamor, Neus Terol, María José González-Barca, Eva González, Marcos Ferrà, Christelle Abella, Eugenia Delgado, Julio Garcia-Marco, Jose A. Gonzalez, Yolanda Carbonell, Felix Ferrer, Secundino Monzo, Encarna Jarque, Isidro Muntanola, Ana Constants, Mireia Escoda, Lourdes Montserrat, Emili